Allergy Therapeutics (AGY)


Latest News

Share of the week: Tipped to double again

Just weeks after we covered its final results, this company's share price has surged and could rise much further, according...

New data from novel adjuvant system

RNS Number: 0772M Allergy Therapeutics PLC 10 October 2016 10 October 2016 Al l e r g y Th e r a p e u ti cs p l c (" A l l e r gy T he r a peu t i cs" or t he " C o m p a n y " ) Allergy Therapeutics presents enhanced efficacy data in a malaria vaccine model with its novel adjuvant system Data to be presented today at the World Vaccine Congress demonstrates signific...

Issue of equity in respect of exercise of options

RNS Number: 5040L Allergy Therapeutics PLC 03 October 2016 3 October 2016 Allergy Therapeutics plc ("Allergy Therapeutics" or the "Company") Issue of equity in respect of the exercise of options Allergy Therapeutics (AIM:AGY) , the fully integrated specialty pharmaceutical company specialising in allergy vaccines, announces the issue and allotment of 3,441,000 ...

Director Deals - Allergy Therapeutics PLC (AGY)

Peter Jensen, Chairman, bought 30,000 shares in the company on the 29th September 2016 at a price of 19.25p. The Director ...

All News

14-10-16Share of the week: Tipped to double againInteractive Investor
10-10-16New data from novel adjuvant systemRNS
03-10-16Issue of equity in respect of exercise of optionsRNS
29-09-16Director Deals - Allergy Therapeutics PLC (AGY)StockMarketWire
29-09-16Director/PDMR ShareholdingRNS
28-09-16Director Deals - Allergy Therapeutics PLC (AGY)StockMarketWire
28-09-16Director/PDMR ShareholdingRNS
26-09-16Allergy Therapeutics tipped to bounce backInteractive Investor
26-09-16Director Deals - Allergy Therapeutics PLC (AGY)StockMarketWire
26-09-16Director/PDMR ShareholdingRNS
26-09-16Hardman Research: Performance drives market shareRNS
26-09-16Allergy Therapeutics revenues up StockMarketWire
26-09-16Allergy Therapeutics revenues up StockMarketWire
26-09-16Allergy Therapeutics Preliminary ResultsRNS
21-09-16Broker Forecast - Numis issues a broker note on Allergy Therapeutics PLCStockMarketWire
21-09-16Allergy Therapeutics options exercised StockMarketWire
20-09-16Issue of equity in respect of exercise of optionsRNS
05-09-16Allergy Therapeutics schedules FY results StockMarketWire
05-09-16Notice of Preliminary ResultsRNS
31-08-16Allergy Therapeutics Plc to present at the Shares Investor Evening in London on 27th September 2016StockMarketWire
13-07-16Trading UpdateRNS
08-07-16Results of mite immunotherapy Acarovac PlusTRNS
27-06-16Findings from mEEC dose range finding study G204RNS
13-06-16Allergy Therapeutics' satellite symposium at EAACIStockMarketWire
13-06-16Allergy hosts Satellite Symposium at EAACIRNS
10-06-16Appointment of Finance DirectorRNS
18-05-16Why GlaxoSmithKline plc, Allergy Therapeutics plc and Consort Medical plc are a dying breedMotley Fool
09-05-16Allergy Therapeutics positive data from PQBirch204 studyStockMarketWire
09-05-16Positive Phase II DataRNS
21-04-16This list of shares keeps outperformingInteractive Investor
23-03-16Allergy Therapeutics options exercised StockMarketWire
23-03-16Issue of equity in respect of options exerciseRNS
17-03-16Allergy Therapeutics FD resigns StockMarketWire
17-03-16Board ChangeRNS
14-03-16Allergy Therapeutics grants options under LTIP StockMarketWire
11-03-16Grant of Options under Long Term Incentive PlanRNS
10-03-16Broker Forecast - Panmure Gordon issues a broker note on Allergy Therapeutics PLCStockMarketWire
08-03-16Interim Results for the six months ended 31/12/15RNS
24-02-16Hardman & Co Research Report: Development ProgressRNS
23-02-16Allergy Therapeutics schedules interim resultsStockMarketWire

RSS feeds

  • Editorial news feed for LSE:AGY Editorial
  • Regulatory news feed for LSE:AGY Regulatory